XML 19 R8.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net income $ 3,290 $ 16,698
Adjustments to reconcile net income to cash flow from operating activities:    
Depreciation and amortization 129,494 118,521
Accretion of loan discounts and premiums, net (4,038) (4,014)
Amortization of deferred financing costs, net 2,065 1,809
Stock compensation expense 5,480 5,797
Gain on sale of real estate assets, net 0 (1,496)
Loss on extinguishment of debt 0 67
Amortization related to derivative instruments 450 506
Non-cash casualty losses 1,195 400
Equity in loss from investments in unconsolidated real estate entities 1,883 1,151
Other loss 191 103
Changes in assets and liabilities:    
Other assets (917) 3,077
Accounts payable and accrued expenses (2,729) 1,379
Accrued interest payable (81) (815)
Other liabilities (48) (569)
Cash flow provided by operating activities 136,235 142,614
Cash flows from investing activities:    
Acquisition of real estate properties (29,392) (58,637)
Escrow deposits for pending real estate acquisitions 0 (3,818)
Cash acquired in consolidation of unconsolidated real estate entity 94 0
Investments in unconsolidated real estate entities (16,475) (16,096)
Proceeds from dispositions of real estate properties, net 0 109,203
Capital expenditures (63,889) (53,677)
Real estate development expenditures (4,085) (12,242)
Proceeds from insurance claims 779 925
Cash flow used in investing activities (112,968) (34,342)
Cash flows from financing activities:    
(Costs) proceeds from issuance of common stock, net (115) 49,883
Proceeds from unsecured revolver and term loan 677,000 243,414
Unsecured revolver, secured credit facility and term loan repayments (461,102) (223,000)
Mortgage principal repayments and payoffs (122,046) (94,423)
Payment for deferred financing costs (2,646) (5,636)
Distributions on common stock (80,602) (74,113)
Distributions to noncontrolling interests (2,021) (1,902)
Payment for debt extinguishment 0 (1)
Repurchase of shares related to equity award tax withholding (2,724) (3,420)
Repurchase of common stock, including repurchase costs (29,936) 0
Cash flow used in financing activities (24,192) (109,198)
Net change in cash, cash equivalents, and restricted cash (925) (926)
Cash, cash equivalents, and restricted cash, beginning of period 47,622 43,452
Cash, cash equivalents, and restricted cash, end of the period 46,697 42,526
Reconciliation of cash, cash equivalents, and restricted cash to the Condensed Consolidated Balance Sheets    
Cash and cash equivalents 22,513 19,491
Restricted Cash 24,184 23,035
Total cash, cash equivalents, and restricted cash, end of period $ 46,697 $ 42,526